"Teprotumumab for inactive thyroid eye disease? The jury is still out.". Dosiou C. J Clin Endocrinol Metab 2024 Jan 27:dgae052. doi: 10.1210.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Dosiou C. "Teprotumumab for inactive thyroid eye disease? The jury is still out.". J Clin Endocrinol Metab 2024 Jan 27:dgae052. doi: 10.1210.
PMID: 38279938